Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation-Reference-Cited by-同舟云学术

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

Published:2017-08-10 Issue:6 Volume:377 Page:523-533
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Robson Mark,Im Seock-Ah,Senkus Elżbieta,Xu Binghe,Domchek Susan M.,Masuda Norikazu,Delaloge Suzette,Li Wei,Tung Nadine,Armstrong Anne,Wu Wenting,Goessl Carsten,Runswick Sarah,Conte Pierfranco

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1706450

Cited by 2420 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single crystal XRD analysis, Molecular docking, DFT studies, Hirshfeld analysis, antioxidant and anticancer activities of three natural carboxylic acids identified in Carica papaya leaves;Journal of Molecular Structure;2024-12

2. Targeted gene panel sequencing of liquid and tissue biopsies reveals actionable genomic alterations in Ghanaian metastatic breast cancer cases;Translational Oncology;2024-11

3. Multispectral breast image grayscale and quality enhancement by repeated pair image registration & accumulation method;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-11

4. Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review;Cancer Treatment Reviews;2024-11

5. Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study;The Breast;2024-10